Transfusion transmitted bacterial infectious (TTBI) with blood component accountability score 2: Retrospective analysis of the French e-fit database 2000-2007 [Les infections bactériennes transmises par transfusion avec imputabilité 2 du PSL: analyse rétrospective de la base e-FIT de 2000 à 2007]
Delbosc A.,Hemovigilance |
Lafeuillade B.,Hemovigilance |
Petermann R.,Direction des laboratoires et des controles |
Eb F.,Laboratoire Of Bacteriologie |
Ounnoughene N.,Unite dhemovigilance
Transfusion Clinique et Biologique | Year: 2011
Purpose of the study: Transfusion transmitted bacterial infection is an adverse reaction occurring in a patient during blood transfusion and due to the presence of bacteria in the blood component. For each transfusion transmitted bacterial infection suspicion, clinical and biological investigations should allow to either affirm the accountability of the transfused product in the occurrence of the infection (accountability score 4) or exclude it (accountability score 0). However, among 60,175 adverse reaction sheets extracted from the French e-FIT database (AFSSAPS), 143 are classified as transfusion transmitted bacterial infection diagnosis and 97 of them show a score of accountability 2 (possible). This study aims to analyze these 97 adverse reaction sheets and search for the reasons that led the haemovigilance network actors not to refine the degree of accountability in line with an exclusion or a confirmation of transfusion origin. Method: During collective reading sessions, each adverse reaction sheet among the 97 extracted was re-analyzed with an accountability criteria grid, built beforehand, and proposed in the technical guide sheet for transfusion transmitted bacterial infection (e-Fit AFSSAPS). Results: Among the 97 analyzed adverse reaction sheets with a score accountability of 2: 12.4 % were considered as " non-analysable" ; 54% were reclassified in another diagnosis category: non haemolytic febrile reaction (n= 12), unknown diagnosis (n= 17); patient infection before transfusion (n= 23); blood component's " smear" (n= 9); retrograde contamination of blood component (n= 5). Finally, only 18.5% adverse reaction sheets (n= 18) were maintained with a true diagnosis of transfusion transmitted bacterial infection an accountability score of 2. These cases were in agreement with those described in number 2, 3 or 4 in the annex sheet " Fiche Technique TTBI" 70% of adverse reaction sheets reclassified under another diagnosis as transfusion transmitted bacterial infection had been declared between 2000 and 2004. In order to improve transfusion transmitted bacterial infection suspicions diagnosis approach and to guide the French haemovigilance network in the investigations following a transfusion transmitted bacterial infection suspicion, the group propose recommendations after each adverse reaction sheets category analysis. Conclusion: The improvement measures taken as part of the French haemovigilance declaration framework allowed to perfect the data quality of transfusion transmitted bacterial infection. Progresses are still to be made to improve clinical and biological declaration, in order to precise the accountability of a blood component in the occurrence of an adverse transfusion transmitted bacterial infection effect. Tracking transfusion transmitted bacterial infection notifications by a group of experts at the national level is still recommended. © 2010 Elsevier Masson SAS.
Simultaneous determination of artesunate and amodiaquine in fixed-dose combination by a RP-HPLC method with double UV detection: Implementation in interlaboratory study involving seven African National Quality Control Laboratories
Le Vaillant Y.,Direction des Laboratoires et des Controles |
Brenier C.,Direction des Laboratoires et des Controles |
Grange Y.,Direction des Laboratoires et des Controles |
Nicolas A.,Direction des Laboratoires et des Controles |
And 9 more authors.
Chromatographia | Year: 2012
The fixed-dose combination artesunate (AS)-amodiaquine (AQ) is one of the most widely used treatments for uncomplicated falciparum malaria. It is currently proposed to the inclusion in the model list of essential medicines of World Health Organization and has been recently prequalified. Until now, no satisfactory method for the simultaneous determination of the two active ingredients had been available. Thus, a reversed phase high performance liquid chromatography for the quantitative determination of AQ and AS was developed and validated. Chromatography was performed using an end-capped octadecylsilyl silica gel column (100 × 4.6 mm, 3 μm) with a binary gradient using aqueous phase containing potassium dihydrogen phosphate (10 mM) and acetonitrile. Taking into consideration the physico-chemical characteristics of the two compounds related to their ionization, the use of a counter ion was necessary to ensure the retention of AQ in a reversed phase system simultaneously to AS. Thus, aqueous mobile phase was adjusted to pH 3.0 and the chosen counter ion was sodium 1-octanesulfonate (100 mM). In these conditions, the retention times were about 4 min for AQ and 10 min for AS with UV detection at 300 and 210 nm, respectively. Method was then validated according to ICH guideline (specificity/linearity/accuracy/precision) and potential interferences with excipients and degradation products were checked. It has also been used for an interlaboratory study involving seven African National Quality Control Laboratories and Afssaps (Agence française de sécurité sanitaire des produits de santé) laboratory. The results demonstrate that this rapid and simple method can be easily used by official laboratories for routine control, market survey and for the detection of potential substandard medicines which are very frequent in African countries. © Springer-Verlag 2012.